Applications of 2-Amino-6-Methyl-4-Pyrimidinol in Industrial Manufacturing

As a direct manufacturer of 2-Amino-6-Methyl-4-Pyrimidinol, we support key global industries that require consistent purity and reliable supply for formulation and process integration. Our advanced production and quality systems meet stringent standards required by downstream sectors. Below, you can find detailed application profiles across recognized, regulation-driven fields where this raw material plays a critical role in finished products.

1. Pharmaceutical Intermediate Synthesis

Leading pharmaceutical companies incorporate 2-Amino-6-Methyl-4-Pyrimidinol during the synthesis of various pyrimidine-based APIs, especially in anti-viral and anti-cancer research. This intermediate enters early-stage heterocycle building to yield key active ingredients prescribed in regulated drug regimes.

Industry compliance standards

• ICH Q7 Guidelines for GMP of APIs
• USP and EP standards for pharmaceutical raw materials
• FDA 21 CFR Part 210/211 Current Good Manufacturing Practice
• EU Directive 2001/83/EC for medicinal product composition

Typical usage ratio

• Ranges from 0.5 molar equivalents to 1.3 equivalents, depending on the target molecule route and yield requirements

Downstream process integration

• Added during amidation or cyclization steps for pyrimidine core formation in batch reactor vessels; purity adjusted based on desired downstream conversion rates and impurity thresholds

Final product types

• Branded and generic anti-viral pharmaceuticals (e.g., nucleoside analogs)
• Oncology drug intermediates
• Diagnostic imaging reagents containing pyrimidine motifs

2. Agrochemical Active Ingredient Manufacturing

Agrochemical formulators use this compound as a strategic intermediate when synthesizing herbicidal and fungicidal actives with pyrimidinyl backbones. Consistency in chemical profile is critical, as regulatory scrutiny over agricultural chemicals requires tight batch-to-batch quality.

Industry compliance standards

• FAO Specifications for Plant Protection Products
• ISO 9001:2015 for chemical raw material suppliers
• REACH (EC 1907/2006) substance registration and notification requirements
• EPA 40 CFR Part 158 for pesticide chemical composition

Typical usage ratio

• Usually 3–12% total mass in core synthesis mixtures, adjusted based on catalyst loading and desired active moiety output

Downstream process integration

• Introduced during initial condensation or ring-closure reactions for construction of substituted pyrimidines; contributes directly to desired substitution pattern in technical grade actives

Final product types

• Systemic herbicide technical concentrates
• Broad-spectrum fungicide pre-mixes
• Tank-mix compatible agricultural actives

3. Specialty Dye and Pigment Synthesis

Industrial dye producers value 2-Amino-6-Methyl-4-Pyrimidinol as a key precursor when manufacturing high-performance pyrimidine-containing azo and reactive dyes. These dyes are specified for demanding textile and inkjet applications, where stability and dye uptake depend on controlled aromatic substitution.

Industry compliance standards

• ZDHC Manufacturing Restricted Substances List (MRSL)
• Oeko-Tex Standard 100 (textile dye acceptability)
• ISO 14001:2015 for environmental management
• REACH Annex XVII for restricted chemicals in dyes

Typical usage ratio

• Typically added at 1–5% weight of total dye mass, with fine-tuning for shade strength, molecular weight, and solubility profile

Downstream process integration

• Fed into aromatic coupling or diazotization stages within continuous-flow or batch dye reactors; input ratio directly impacts hue, fastness, and compatibility

Final product types

• High-brightness reactive textile dyes
• Solvent-stable printing pigments
• Inkjet colorants for digital textile and paper applications

4. Analytical Reagent and Diagnostic Kit Components

Diagnostic kit manufacturers employ 2-Amino-6-Methyl-4-Pyrimidinol as a building block in the development of proprietary assay reagents. The compound’s unique reactivity supports site-specific labeling and chromogenic substrate systems, directly affecting assay selectivity and stability under storage.

Industry compliance standards

• ISO 13485:2016 for medical devices and reagent suppliers
• CLSI guidelines for reagent lot consistency and traceability
• EU Regulation (EU) 2017/746 for in vitro diagnostic medical devices (IVDR)
• US FDA 21 CFR Part 820 QSR for devices and diagnostics

Typical usage ratio

• Generally formulated at 0.1–2% weight/volume of diagnostic mixture, precisely titrated for reaction kinetics and detection thresholds

Downstream process integration

• Used as an input during synthesis of colorimetric or fluorescent molecular probes; can also be directly blended in enzyme substrate cocktails under controlled temperature and pH

Final product types

• Clinical diagnostic rapid test kits
• Enzymatic assay reagents used in laboratory automation
• High-purity reference solutions for instrument calibration